Article

Update on Eudamed and its implications for vigilance in the EU

21 Feb 2012, Erik Vollebregt This will be a very short post, because everything I could write down on the subject is in the interview I had with Ashley Yeo of Scrip Regulatory Affairs, that kindly consented…